VERONA PHARMA PLC - ADR (VRNA) Stock Analyst Earnings Estimates
NASDAQ:VRNA - Nasdaq - US9250501064 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 460K -98.85% | -100.00% | 42.279M | 420.86M 895.44% | 748.13M 77.76% | 1.081B 44.49% | 1.624B 50.23% | 2.146B 32.14% | 2.679B 24.84% | 3.208B 19.75% | 3.689B 14.99% | |
| EBITDA YoY % growth | -75.11M -3.34% | -66.892M 10.94% | -153.569M -129.58% | 41.004M 126.70% | 715.73M 1,645.51% | 1.356B 89.46% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -75.75M -3.33% | -67.569M 10.80% | -154.627M -128.84% | 40.112M 125.94% | 267.88M 567.83% | 586.6M 118.98% | 958.82M 63.45% | 1.363B 42.15% | 1.801B 32.13% | 2.209B 22.65% | 2.597B 17.56% | |
| Operating Margin | -16,467.39% | N/A | -365.73% | 9.53% | 35.81% | 54.26% | 59.04% | 63.51% | 67.23% | 68.86% | 70.40% | |
| EPS YoY % growth | -1.11 -14.43% | -0.68 38.74% | -2.16 -217.65% | 0.21 109.68% | 1.54 635.37% | 3.07 99.34% | 0.59 -80.87% | 0.87 47.83% | 1.21 40.00% | 1.69 39.50% | 2.44 43.98% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.24 142.93% | 0.23 157.80% | 0.25 257.25% |
| Revenue Q2Q % growth | 121.09M 2,053.09% | 127.32M 247.35% | 146.37M 91.95% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | 21.919M 153.90% | 24.282M 232.41% | 41.683M 504.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.13 114.77% | 0.05 | 0.08 | 154.90% |
| Q1 2025 Q2Q % growth | -0.16 50.00% | -0.15 | -0.01 | -4.58% |
| Q4 2024 Q2Q % growth | -0.40 -122.22% | -0.30 | -0.10 | -34.07% |
| Q3 2024 Q2Q % growth | -0.56 -211.11% | -0.51 | -0.05 | -9.80% |
| Q2 2024 Q2Q % growth | -0.88 -1,000.00% | -0.30 | -0.58 | -192.46% |
| Q1 2024 Q2Q % growth | -0.32 -33.33% | -0.17 | -0.15 | -91.30% |
| Q4 2023 Q2Q % growth | -0.18 -12.50% | -0.27 | 0.09 | 32.13% |
| Q3 2023 Q2Q % growth | -0.18 21.74% | -0.29 | 0.11 | 36.97% |
| Q2 2023 Q2Q % growth | -0.08 75.00% | -0.30 | 0.22 | 73.19% |
| Q1 2023 Q2Q % growth | -0.24 40.00% | -0.19 | -0.05 | -23.84% |
| Q4 2022 Q2Q % growth | -0.16 60.00% | -0.10 | -0.06 | -53.04% |
| Q3 2022 Q2Q % growth | -0.23 -243.75% | -0.17 | -0.06 | -37.49% |
| Q2 2022 Q2Q % growth | -0.32 13.51% | -0.39 | 0.07 | 16.89% |
| Q1 2022 Q2Q % growth | -0.40 -11.11% | -0.45 | 0.05 | 10.87% |
| Q4 2021 Q2Q % growth | -0.40 | -0.49 | 0.09 | 19.14% |
| Q3 2021 Q2Q % growth | 0.16 134.78% | -0.37 | 0.53 | 143.57% |
| Q2 2021 Q2Q % growth | -0.37 43.94% | -0.45 | 0.08 | 17.18% |
| Q1 2021 Q2Q % growth | -0.36 62.11% | -0.48 | 0.12 | 25.51% |
| Q4 2020 Q2Q % growth | -0.40 45.21% | -0.36 | -0.04 | -12.04% |
| Q3 2020 Q2Q % growth | -0.46 51.37% | -0.22 | -0.24 | -108.14% |
| Q2 2020 Q2Q % growth | -0.66 24.14% | -0.48 | -0.18 | -36.70% |
| Q1 2020 Q2Q % growth | -0.95 -77.24% | -0.67 | -0.28 | -42.56% |
| Q4 2019 Q2Q % growth | -0.73 | -1.12 | 0.39 | 34.64% |
| Q3 2019 Q2Q % growth | -0.95 | -0.81 | -0.14 | -16.66% |
| Q2 2019 Q2Q % growth | -0.87 | -0.77 | -0.10 | -13.35% |
| Q1 2019 Q2Q % growth | -0.54 | -0.50 | -0.03 | -6.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 103.138M | 93.991M | 9.147M | 9.73% |
| Q1 2025 Q2Q % growth | 76.256M | 54.437M | 21.819M | 40.08% |
| Q4 2024 Q2Q % growth | 36.655M | 33.712M | 2.943M | 8.73% |
| Q3 2024 Q2Q % growth | 5.624M | 2.055M | 3.569M | 173.67% |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 460K | 3.643M | -3.183M | -87.37% |
| Q3 2022 Q2Q % growth | -100.00% | 3.643M | -3.643M | -100.00% |
| Q3 2021 Q2Q % growth | 40M | 4.25M | 35.75M | 841.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -178.55% | 70.91% | 0% | -28.32% |
| Revenue | 0% | 12.91% | 0.15% | 8.32% |